Skip to main content

Amobarbital Sodium Injection Shortage

Last Updated: September 22, 2024
Status: Current

Products Affected - Description
    • Amytal lyophilized powder for injection, Bausch Health, 500 mg, vial, 1 count, NDC 00187-4303-05 - discontinued
Reason for the Shortage
    • Bausch Health discontinued Amytal in August 2024.
    • Bausch Health was the sole supplier of amobarbital injection.
Available Products
    • There are no presentations available

Estimated Resupply Dates

    • Bausch Health has discontinued Amytal 500 mg vials.

Updated

Updated September 22, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 12, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.